Fabry Disease Treatment Market 2027 by Drug Type | The Insight Partners

Fabry Disease Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others)

Report Code: TIPRE00008240 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Fabry disease is one of a group of conditions known as lysosomal storage diseases. It is a rare genetic disease that can affect many parts of the body, including the kidneys, heart, and skin. The patient suffers from a lack of an alpha-galactosidase enzyme that manages to progressive organ dysfunction. Abnormal accumulation of a particular fatty matter is called globotriaosylceramide and is mainly responsible for the development of fabry diseases.

MARKET DYNAMICS

The fabry disease treatment market is anticipated to grow due to the support of government bodies for the treatment of Fabry diseases such as the Food and Drug Administration (FDA). However, lack of awareness about advancements in genetic sciences, technological limitations in a particular region of the world is restraining the market growth. Moreover, extensive R&D activities are driving the fabry disease treatment market in the forecast period.

MARKET SCOPE

The "Fabry Disease Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in fabry disease treatment market with detailed market segmentation by drug type, and geography. The fabry disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in fabry disease treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The fabry disease treatment market is segmented on the basis of drug type. Based on drug type the market is segmented as enzyme replacement therapy (ERT), chaperone treatment, substrate reduction therapy (SRT) and others.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in fabry disease treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fabry disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting fabry disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fabry disease treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in fabry disease treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in fabry disease treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in fabry disease treatment market in the global market. Below mentioned is the list of few companies engaged in the fabry disease treatment market.

The report also includes the profiles of key in fabry disease treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Amicus Therapeutics Inc.
  •  Avrobio Inc.
  •  Greenovation Biotech GmbH
  •  Idorsia Pharmaceuticals Ltd.
  •  ISU Abxis Co Ltd.
  •  JCR Pharmaceuticals Co Ltd
  •  Moderna Therapeutics Inc.
  •  Protalix Biotherapeutics Inc.
  •  Sanofi S.A.
  •  Shire Plc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fabry Disease Treatment Market - By Drug Type
1.3.2 Fabry Disease Treatment Market - By Region
1.3.2.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. FABRY DISEASE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. FABRY DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. FABRY DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. FABRY DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. FABRY DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. FABRY DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENZYME REPLACEMENT THERAPY (ERT)
7.3.1. Overview
7.3.2. Enzyme Replacement Therapy (ERT) Market Forecast and Analysis
7.4. CHAPERONE TREATMENT
7.4.1. Overview
7.4.2. Chaperone Treatment Market Forecast and Analysis
7.5. SUBSTRATE REDUCTION THERAPY (SRT)
7.5.1. Overview
7.5.2. Substrate Reduction Therapy (SRT) Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis

8. FABRY DISEASE TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Fabry Disease Treatment Market Overview
8.1.2 North America Fabry Disease Treatment Market Forecasts and Analysis
8.1.3 North America Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.1.4 North America Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.1.4.1 United States Fabry Disease Treatment Market
8.1.4.1.1 United States Fabry Disease Treatment Market by Drug Type
8.1.4.2 Canada Fabry Disease Treatment Market
8.1.4.2.1 Canada Fabry Disease Treatment Market by Drug Type
8.1.4.3 Mexico Fabry Disease Treatment Market
8.1.4.3.1 Mexico Fabry Disease Treatment Market by Drug Type
8.2. EUROPE
8.2.1 Europe Fabry Disease Treatment Market Overview
8.2.2 Europe Fabry Disease Treatment Market Forecasts and Analysis
8.2.3 Europe Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.2.4 Europe Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Fabry Disease Treatment Market
8.2.4.1.1 Germany Fabry Disease Treatment Market by Drug Type
8.2.4.2 France Fabry Disease Treatment Market
8.2.4.2.1 France Fabry Disease Treatment Market by Drug Type
8.2.4.3 Italy Fabry Disease Treatment Market
8.2.4.3.1 Italy Fabry Disease Treatment Market by Drug Type
8.2.4.4 Spain Fabry Disease Treatment Market
8.2.4.4.1 Spain Fabry Disease Treatment Market by Drug Type
8.2.4.5 United Kingdom Fabry Disease Treatment Market
8.2.4.5.1 United Kingdom Fabry Disease Treatment Market by Drug Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Fabry Disease Treatment Market Overview
8.3.2 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis
8.3.3 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.3.4 Asia-Pacific Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Fabry Disease Treatment Market
8.3.4.1.1 Australia Fabry Disease Treatment Market by Drug Type
8.3.4.2 China Fabry Disease Treatment Market
8.3.4.2.1 China Fabry Disease Treatment Market by Drug Type
8.3.4.3 India Fabry Disease Treatment Market
8.3.4.3.1 India Fabry Disease Treatment Market by Drug Type
8.3.4.4 Japan Fabry Disease Treatment Market
8.3.4.4.1 Japan Fabry Disease Treatment Market by Drug Type
8.3.4.5 South Korea Fabry Disease Treatment Market
8.3.4.5.1 South Korea Fabry Disease Treatment Market by Drug Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Fabry Disease Treatment Market Overview
8.4.2 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis
8.4.3 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.4.4 Middle East and Africa Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Fabry Disease Treatment Market
8.4.4.1.1 South Africa Fabry Disease Treatment Market by Drug Type
8.4.4.2 Saudi Arabia Fabry Disease Treatment Market
8.4.4.2.1 Saudi Arabia Fabry Disease Treatment Market by Drug Type
8.4.4.3 U.A.E Fabry Disease Treatment Market
8.4.4.3.1 U.A.E Fabry Disease Treatment Market by Drug Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Fabry Disease Treatment Market Overview
8.5.2 South and Central America Fabry Disease Treatment Market Forecasts and Analysis
8.5.3 South and Central America Fabry Disease Treatment Market Forecasts and Analysis - By Drug Type
8.5.4 South and Central America Fabry Disease Treatment Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Fabry Disease Treatment Market
8.5.4.1.1 Brazil Fabry Disease Treatment Market by Drug Type
8.5.4.2 Argentina Fabry Disease Treatment Market
8.5.4.2.1 Argentina Fabry Disease Treatment Market by Drug Type

9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

10. FABRY DISEASE TREATMENT MARKET, KEY COMPANY PROFILES
10.1. AMICUS THERAPEUTICS INC.
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. AVROBIO INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. GREENOVATION BIOTECH GMBH
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. IDORSIA PHARMACEUTICALS LTD.
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. ISU ABXIS CO LTD.
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. JCR PHARMACEUTICALS CO LTD
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. MODERNA THERAPEUTICS INC.
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. PROTALIX BIOTHERAPEUTICS INC.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SANOFI S.A.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SHIRE PLC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments

11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Amicus Therapeutics Inc.
2. Avrobio Inc.
3. Greenovation Biotech GmbH
4. Idorsia Pharmaceuticals Ltd.
5. ISU Abxis Co Ltd.
6. JCR Pharmaceuticals Co Ltd
7. Moderna Therapeutics Inc.
8. Protalix Biotherapeutics Inc.
9. Sanofi S.A.
10. Shire Plc.
TIPRE00008240
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking